Introduction
Fungal infections are a major health issue counterintuitively fuelled by the developments in medical care. The great majority of clinically relevant fungi are opportunistic pathogens for patients who receive immunosuppressive therapy, broad spectrum antibiotics, chemotherapy, patients with diabetes or HIV infection, etc. Candida yeasts are the most frequent fungal pathogen in humans, being the fourth cause of bloodstream infections [1] , and of these C. albicans is the dominant species. Although much progress has been made in understanding the phenotypic and genotypic C. albicans profiles, still less is known regarding their interaction with the host [2] . This article is an extension of the previous paper dealing with Candida albicans isolates in Romanian patients (see Reference No. 3) , with new results from a further elaborated analysis.
Methods
The investigation was performed on 301 clinical yeast isolates collected in five tertiary hospitals from different regions of Romania during 2010-2016 (i.e. Iași, București, Cluj-Napoca, Timișoara, and Tîrgu Mureș) as follows: 62 were recovered from confirmed bloodstream infections (BSI), 66 from other deep-seated mycoses (DEEP), and 173 from superficial mycoses (SUP). DEEP mycoses were represented by the following samples: urinary tract in non-catheterized patients (U), urinary tract of HIV-infected patients (U-HIV), cerebrospinal fluid from HIV-infected patients (CSF), sputum (S), sputum from tuberculosis patients (S-TB), bronchial aspirate (BA), bronchial aspirate from tuberculosis patients (BA-TB), and laparotomy surgical drain (SD). SUP infection samples were divided into: oral samples from patients with diabetes (OS-D), oral samples from pregnant patients (OS-P), oral samples from HIV-infected patients (OS-HIV), oral samples from patients with denture (OS-D), oral samples from patients with tuberculosis (OS-TB), oral samples in patients with other predisposing conditions (OS-OC), gastrointestinal tract (GT), faeces samples (F), faeces from HIV-infected patients (F-HIV), vaginal discharge (VD), vaginal discharge from pregnant women (VD-P), samples from patients with balanitis (B), onychomycosis (O). The isolates were collected from patients who satisfy simultaneously at least two of the following conditions: low birth weight for paediatric patients (<1500 g), old age for adult patients (>65 years), insulin-dependent diabetes mellitus, recent major surgery, broad-spectrum antibiotic therapy, central venous catheter, organ transplantation, prolonged ICU stay (>48h), immunosuppression (HIV infection or other predisposing conditions), total parenteral nutrition or mechanical ventilation. The isolates were submitted to the Laboratory of Antimicrobial Chemotherapy from the Department of Public Health of "Ion Ionescu de la Brad" University, Iasi, Romania. All isolates were checked for purity and stored in 10% glycerol at -70°C. The final identification was performed using ID32C strips (bioMérieux, France). For DNA extraction, 4-5 individual colonies of C. albicans were picked up from Sabouraud Dextrose Agar (SDA) plates and suspended in 200 μL distilled water in a sterile Eppendorf tube. DNA was obtained by lysing the yeast cells at 95°C for 5 min followed by immersing in ice and centrifugation. PCR to detect the genotypes was performed according to the method previously described [4] [5] using the primers CA-NT-L (5'-ATAAGG-GAAGTCGGCAAAATAGATCCGTAA-3') and CA-NT-R (5'-CCTTGGCTGTGGTTTC-GCTAGATAGTAGAT-3'). All PCR amplification reactions were performed in 50 μL of distilled water containing 2.0 μL of each primer, 2.0 μL of genomic DNA (5 μg/mL) and one PCR bead (Ready-to-Go PCR beads; Amersham Pharmacia Biotech, Piscataway, NJ, USA). The PCR conditions were: denaturation for 5 min at 93°C, 40 cycles of 93°C for 30 s, 55°C for 45 s, and 72°C for 45 s and a final extension at 72°C for 10 min. The products were analysed using DNA microfluidic chips of Experion Automated Electrophoresis System (Bio-Rad, USA). The genotypes of C. albicans can be divided into 5 groups by the size of DNA amplified fragments (450 bp for group A, 840 bp for group B, 450 and 840 bp for group C, 1080 bp for group D and 1400 bp for group E) [5] [6] [7] . The results were submitted to a preliminary multiple correspondence analysis (MCA) which had been assessed using XlStat-Ecology 2018.7 version. Basic descriptive statistics, chi-square test, and one-way ANOVA test were used to interpret the obtained data. For ANOVA test, p<0.05 was considered statistically significant.
Results
According to the site from which strains were isolated, 57.47% of them were from SUP infections, 20.60% from BSI, and 21.93% DEEP (see Table 1 ). C. albicans strains were divided into three different groups, based on the length of polymerase chain reaction (PCR) amplification products, namely genotype A with 55.81%, B with 14.62%, and C with 29.57% respectively (see Figure 1) . Genotypes D and E were not detected. Regarding SUP, most of the samples were from OS-OC (24.28%) and VD (22.54%), while from DEEP, the majority of the samples were from S (43.94%) and BA-TB (22.72%) (see Table 1 ).
In many samples (n=168), genotype A was the predominant genotype, like those from VD-P (64.28%), OS-OC (57.15%) or F (72.72%). Genotype C was found mostly in OS-HIV (46.15%) ( Table 1) . Genotype B was mostly found in samples from U and SD (33.33% and 28.57%, respectively), and also from BA-TB (26.66%). It can also be noticed that OS-HIV had genotype C (46.15%), instead of genotype A, which was found in oral samples from other groups of patients (66.67% to 100%). According to the correspondence analysis, no significant correlation was noticed between the sites of detection of isolates and their genotype (p = 0.449). Instead, a significant correlation between HIV-infected status and genotype C prevalence (p<0.0001) was observed for F-HIV, U-HIV, and OS-HIV. This fact was not found for the non-HIV samples with the same source (p = 0.439).
Discussions
Whether the virulence of C. albicans is related to genotypes remains a continuous debate. One study proves that genotype A was more prevalent among invasive strains and genotype B and C were more prevalent among none-invasive strains [8] . Al-Karaawi et al. reported that genotype A is the most predominant type in patients with oral Candida infections [9] . Our study proves that genotype A is not only dominant in patients with oral candidiasis, but also in patients with other SUP mycoses, DEEP, and also with BSI. Genotype determinations of C. albicans strains tend to be genetically similar to each other, when originating from similar population groups, in relation to the immune condition, anatomic site, or geographical location [9] . Genotypes A, B, and C were also detected in 73 strains sampled from dental biofilms of severe early childhood caries [5] . In another study, genotypes were detected by analysing 151 strains of C. albicans (71 samples from infant patients with cutaneous candidiasis and 61 samples from females with vaginal candidiasis), and no distinctive association was found between genotype and the site of cutaneous infection [7] . Barros et al. found sixteen genotypes among 56 samples of C. albicans isolated from the oral cavity [4] . A comparison between this study and the previous ones [4] [5] 7] in terms of genotype is difficult due to the different number of strains and also to their prevalence in various clinical conditions, body sites or geographical conditions. Genotype A was predominant in all the examined groups and, surprisingly, genotype C was identified more frequently in isolates sampled from patients with HIV (see Table 1 ). Geno- type C is considered a hybrid of genotypes A and B, containing the intron in only one allele [10] [11] . Despite a significant number of previously published studies on ABC genotypes in Candida albicans, no data concerning the prevalence of genotype C in HIV-infected patients have been reported. Our findings could be explained by the higher resistance of genotype C isolates to polymorphonuclear neutrophils (PMNs) attack compared with genotypes A and B isolates [12] correlated with an impaired PMNs activity that usually occurs during HIV infection [13] .
The results of our study should be interpreted in the light of some epidemiological limitations linked to an imbalanced number of isolates from different clinical sites or various general conditions of the patients.
Conclusions
No significant correlation was found between the infection site and a particular genotype. C. albicans is a diploid organism and its pathogenicity is linked to a series of inherent and environmental factors and it is mostly related to the host immunological status. However, in order to prove the above statements, our study emphasizes a significant correlation between the genotype C occurrence and the HIV-infected status in patients. 
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